NORCROSS, Ga.--(BUSINESS WIRE)--Auriga Laboratories, Inc. (OTCBB:ARGA), a specialty pharmaceutical company driving high-growth revenues through acquisition of valuable brand portfolios and innovative drug development programs, today announced the appointment of commercialization expert and biopharmaceutical industry veteran, Stephen C. Glover to the Company’s Board of Directors, where he will provide important background and advice as Auriga expands its prescription drug marketing and product development programs.
